Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:21 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 10,204,089 4.98% | -8,980,705 (-46.81%) | View |
| 2024-02-14 09:02 am Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Avoro Capital Advisors LLC | 13,050,000 6.4% | 13,050,000 (New Position) | View |
| 2024-02-13 5:00 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 17,763,720 8.67% | 3,559,325 (+25.06%) | View |
| 2024-01-24 5:23 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BlackRock Inc. BLK | 18,681,370 9.1% | 3,762,415 (+25.22%) | View |
| 2024-01-24 1:06 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 12,777,003 6.24% | 1,650,142 (+14.83%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 19,184,794 9.95% | 720,050 (+3.90%) | View |
| 2023-02-09 11:12 am Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 14,204,395 7.62% | 4,791,490 (+50.90%) | View |
| 2023-02-06 09:33 am Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 11,126,861 5.97% | 2,877,832 (+34.89%) | View |
| 2023-02-03 4:27 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BlackRock Inc. BLK | 14,918,955 8% | 131,560 (+0.89%) | View |
| 2022-02-14 4:15 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 18,464,744 9.95% | 285,863 (+1.57%) | View |
| 2022-02-09 3:33 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 9,412,905 5.23% | -2,186,429 (-18.85%) | View |
| 2022-02-09 11:33 am Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 8,249,029 4.58% | 940,213 (+12.86%) | View |
| 2022-02-01 5:08 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BlackRock Inc. BLK | 14,787,395 8.2% | -1,472,350 (-9.06%) | View |
| 2021-04-12 09:36 am Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | STATE STREET CORP STT | 7,308,816 4.13% | -3,748,163 (-33.90%) | View |
| 2021-02-16 4:53 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 18,178,881 9.99% | 2,303,756 (+14.51%) | View |
| 2021-02-16 4:30 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | CITADEL ADVISORS LLC | 6,660,717 3.8% | -2,234,718 (-25.12%) | View |
| 2021-02-16 3:16 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Point72 Asset Management L.P. | 3,691,632 2.1% | -4,696,422 (-55.99%) | View |
| 2021-02-11 12:54 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | JANUS HENDERSON GROUP PLC JHG | 0 0% | -9,408,481 (Position Closed) | View |
| 2021-02-10 4:28 pm Sale | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | INTEGRATED CORE STRATEGIES (US) LLC | 286,632 0.2% | -9,688,845 (-97.13%) | View |
| 2021-02-10 10:39 am Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | VANGUARD GROUP INC | 11,599,334 6.57% | 3,477,703 (+42.82%) | View |